Orion Corporation, commonly referred to as Orion, is a Finnish pharmaceutical company headquartered in Espoo, Finland. Founded in 1917, Orion has established itself as a key player in the pharmaceutical and biotechnology industry, with a strong presence in Europe and beyond. The company focuses on developing innovative medicines and diagnostic products, particularly in the fields of oncology, pain management, and central nervous system disorders. Orion's core offerings include prescription pharmaceuticals and over-the-counter products, distinguished by their commitment to quality and research-driven development. With a robust pipeline of new therapies and a reputation for excellence, Orion has achieved notable milestones, including successful collaborations and a growing international market presence. As a trusted name in healthcare, Orion continues to advance its mission of improving patient outcomes through science and innovation.
How does Orion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Orion's score of 71 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Orion Corporation reported total greenhouse gas emissions of approximately 371,000,000 kg CO2e, with emissions distributed across various scopes: 5,625,000 kg CO2e (Scope 1), 5,330,000 kg CO2e (Scope 2, market-based), and a significant 361,961,000 kg CO2e (Scope 3). This represents a notable increase in Scope 3 emissions compared to 2023, where total emissions were about 417,464,000 kg CO2e, with Scope 1 at 5,511,000 kg CO2e and Scope 2 at 8,429,000 kg CO2e (market-based). Orion has set ambitious climate commitments, aiming for carbon neutrality in its operations by 2031. The company has established a target to reduce its Scope 1 and 2 greenhouse gas emissions by 75% by 2025, using 2016 as a baseline. Additionally, Orion has committed to a 70% reduction in absolute Scope 1 and 2 emissions by 2030 from a 2023 base year, with a goal for 78% of its suppliers to adopt science-based targets by 2029. These initiatives reflect Orion's commitment to addressing climate change and reducing its carbon footprint, aligning with industry standards for sustainability and emissions reduction.
Access structured emissions data, company-specific emission factors, and source documents
2007 | 2008 | 2009 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 3,740,000 | 0,000,000 | 0,000,000 | - | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 2 | 21,685,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
Scope 3 | - | - | - | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Orion is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.